James E. Flynn, 10% Owner at Aclaris Therapeutics, Inc. (ACRS), sold 180,565 shares at $6.05 ($1.1M) on 2019-05-10, disclosed to the SEC on 2019-05-13.
Open-market sale of $1.1M ACRS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.05 | 71,869 | $435K | 39.8% |
| 2 | $6.05 | 108,696 | $658K | 60.2% |
| Total | $6.05 avg | 180,565 | $1.1M | 100% |
| Filing → |
| SPRY | SELL | 2025-07-01 | $27.3M | — | Filing → |
| ONCR | SELL | 2022-12-30 | $65K | — | Filing → |
| ONCR | SELL | 2022-12-21 | $23K | — | Filing → |